BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial
BERGEN, Norway, Jan. 7, 2025 /PRNewswire/ — BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase…
